Nke atọ CMC-China 2021
Oge: Septemba 29-30, 2021
Ebe ngosi: Ụlọ Nzukọ CD, Suzhou International Expo Center, Suzhou City, JIangsu Province, China.
Mmekọrịta nke Centralized China's Drug Volume based Purchasing and Medical Insurance Negotiation Policy na-eme ka ihe mgbu nke njikọta ụlọ ọrụ ọgwụ na-eme ka ọ dịkwuo mma ma na-eme ka ụdị ọgwụ dị iche iche dịkwuo mma. A na-emewanye nyocha na nkwenye nke ọgwụ ọhụrụ, ọnụahịa nke mkparịta ụka mkpuchi ahụike belatara, ma gosipụta ya. ewepụrụ ọgwụ na mkpuchi ahụike, na-ahapụ ohere maka ọgwụ nwere ezigbo uru ụlọ ọgwụ: NMPA isonye na ICH na mmejuputa usoro MAH mụbara ọsọ nke mmepụta nke ọrụ ọgwụ ọhụrụ.
Ruo ogologo oge, ụlọ ọrụ na-emepụta ọgwụ lekwasịrị anya na "ihe ọhụrụ" ma leghara ọchịchọ ọgwụ anya n'ụzọ kwekọrọ na ọnọdụ mba na agbụ ụlọ ọrụ ọgwụ niile, dị ka ntinye ọnụ nke API intermediates na ọkọnọ; ma ọ bụ ọwa ahịa nke ọgwụ ọhụrụ.Innovation for innovation's sake bụ nnukwu ụlọ dị n'ikuku.
Kedu ka ụlọ ọrụ ọgwụ na-eji àgwà ndị China ga-aga n'ọdịnihu? Nke a abụghị naanị nsogbu n'akụkụ R & D ọgwụ, kamakwa na agbụ ụlọ ọrụ ọgwụ niile kwesịrị iche echiche.
Septemba 29 ruo 30, 2021, a ga-enwe ogbako China Chemical and Biological Pharmaceutical Industry Conference na Suzhou International Expo Center. Isiokwu nke ogbako a bụ "ijikọta agbụ ụlọ ọrụ ọgwụ niile iji dozie mkpa ọgwụ na-emezughị n'ụzọ kwekọrọ na ọnọdụ mba China. ", Na ogbako, banyere 6000 ~ 8000 sonyere ga-atụle API intermediates, ụzọ inhibitor, na mma na ọhụrụ, mgbe ahụ na isi iyi nke ọhụrụ ọgwụ ọhụrụ n'akụkụ niile iji chọpụta nkà na ụzụ, atumatu na ngwọta.
Ka a na-eme mgbanwe ahịa na atumatu, ụlọ ọrụ ọgwụ kemịkalụ ọdịnala na-emeziwanye ma na-agbanwe, ụlọ ọrụ Biotech ọhụrụ na-eme mkpọtụ, ụlọ ọrụ CXO metụtara preclinical, clinical na CMC na-abawanye ụba. , ọgwụ kemịkal na ọgwụ ndị dị ndụ. Ikikere imekọ ihe ọnụ n'ime/ pụta, mba ofesi merging na nnweta bụkwa ihe a na-ahụkarị.
N'ime ihe ndabere a, anyị na ọtụtụ narị ụlọ ọrụ na-emepụta ọgwụ na-ejikọta ọnụ nke atọ nke China International Biological & Chemical Pharmaceutical Industry Conference (The 3rd CMC-China 2021) na Suzhou, obodo kachasị ukwuu nke ụlọ ọrụ ọgwụ.A na-ahazi forums isiokwu isii na ogbako ahụ, na-ekpuchi akụkụ dum nke macro-molecules & small molecules, generic and innovative drugs, top & down streams chain of active pharmaceutical ingredients (API) and pharmaceutical preparations.
Na ogbako nke 3 CMC-China, ị ga-enweta nkọwa amụma ụlọ ọrụ ọgwụ ọgwụ na nkesa teknụzụ dị oke ọnụ, na-ekpuchi ọgwụ mgbochi, ọgwụ mgbochi na teknụzụ mRNA, ọgwụ ọhụrụ na nnabata ọgwụ jeneriki, nyocha na mmepe, ụlọ ọgwụ na mmepụta, kemịkalụ ndụ ndụ n'ezie. ọgụ technology, wdg Na ogbako, ị nwere ike ịhụ ọzọ azụmahịa ohere na mpaghara nke na-arụsi ọrụ ike ọgwụ Efrata (API), pharmaceutical intermediates na pharmaceutical excipients, nkwakọ ihe, ngwá, ngwá, consumables, yana ọgwụ & clinical CRO, CMO yana ọrụ metụtara MAH.Na ogbako, ị ga-ezute otu ndị enyi ụlọ ọrụ na ndị mmekọ!
Oge nzipu: Sep-28-2021